Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

Autor: Thunnissen, E. Kerr, K.M. Dafni, U. Bubendorf, L. Finn, S.P. Soltermann, A. Biernat, W. Cheney, R. Verbeken, E. Warth, A. Marchetti, A. Speel, E.-J.M. Pokharel, S. Quinn, A.M. Monkhorst, K. Navarro, A. Madsen, L.B. Tsourti, Z. Geiger, T. Kammler, R. Peters, S. Stahel, R.A. Rosell, R. Blackhall, F. Molina, M.A. Weder, W. Finn, S. Hiltbrunner, A. Marti, N. Polydoropoulou, V. Zygoura, P. Nicolson, M. Stevenson, D.A.J. Mathieson, W. Smit, E. Radonic, T. Rulle, U. Curioni, A. Gray, S.G. Gately, K. Barr, M. Meldgaard, P. Madsen, L.B. Savic, S. Lardinois, D. Nackaerts, K. Dooms, C. Wauters, E. Van Der Borght, S. Wrona, A. Rzyman, W. Jassem, J. Dienemann, H. Muley, T. De Luca, G. di Lorito, A. Dingemans, A.-M. Ruland, A. Ferenczy, P. Franklin, L. Baas, P. van de Wiel, B. Camps, C. Martorell, M. for the European Thoracic Oncology Platform Lungscape Consortium

PD-L1, as assessed by immunohistochemistry, is a predictive biomarker for immuno-oncology treatment in lung cancer. Different scoring methods have been used to assess its status, resulting in a wide range of positivity rates. We use the European Thor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::f02fc25a4341656e52192cf3c9795bab
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121206

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.

Autor: Gronnier, Caroline¹ (AUTHOR) caroline.gronnier@chu-bordeaux.fr, Mariette, Christophe^2,3 (AUTHOR) guillaume.piessen@chru-lille.fr, Lepage, Come^4,5 (AUTHOR) come.lepage@u-bourgogne.fr, Monterymard, Carole⁶ (AUTHOR) carole.monterymard@u-bourgogne.fr, Jary, Marine⁷ (AUTHOR) jary.marine@gmail.com, Ferru, Aurélie⁸ (AUTHOR) a.ferru@chu-poitiers.fr, Baconnier, Mathieu⁹ (AUTHOR) mbaconnier@ch-annecygenevois.fr, Adhoute, Xavier¹⁰ (AUTHOR) xadhoute@hopital-saint-joseph.fr, Tavan, David¹¹ (AUTHOR) davidtavan@gmail.com, Perrier, Hervé¹² (AUTHOR) hperrier@hopital-saint-joseph.fr, Guerin-Meyer, Véronique¹³ (AUTHOR) veronique.guerin-meyer@ico.unicancer.fr, Lecaille, Cédric¹⁴ (AUTHOR) lecail@hotmail.com, Bonichon-Lamichhane, Nathalie¹⁵ (AUTHOR) n.bonichon-lamichhane@tivoli-oncologie.fr, Pillon, Didier¹⁶ (AUTHOR) dpillon@ch-bourg01.fr, Cojocarasu, Oana¹⁷ (AUTHOR) ocojocarasu@ch-lemans.fr, Egreteau, Joëlle¹⁸ (AUTHOR) e.girard@ghbs.bzh, D'journo, Xavier Benoit¹⁹ (AUTHOR) xavier.djourno@ap-hm.fr, Dahan, Laétitia²⁰ (AUTHOR) laetitia.dahan@ap-hm.fr, Locher, Christophe²¹ (AUTHOR) clocher@ghef.fr, Texereau, Patrick²² (AUTHOR) patrick.texereau@ch-mdm.fr

Publikováno v: Cancers. Apr2023, Vol. 15 Issue 7, p2188. 14p.

Toward Targeted Therapies in Oesophageal Cancers: An Overview.

Autor: Bregni, Giacomo¹ (AUTHOR) giacomo.bregni@bordet.be, Beck, Benjamin² (AUTHOR) benjamin.beck@ulb.be

Publikováno v: Cancers. Mar2022, Vol. 14 Issue 6, p1522. 26p.